Majority of drug prices start 2007 with an increase

Why This Topic Matters

Quarterly ASP updates can affect reimbursement for commonly billed injectable and oral drugs under Medicare Part B. Understanding which drugs changed, and which policy updates may alter future pricing, helps billing and coding teams stay current with payment revisions.

Article Sections

1. Payment trends for first quarter 2007

   An overview of how Medicare Part B drug payments changed at the start of 2007, including general movement in increases, decreases, and unchanged rates. Also notes the presence of newly added and deleted drug codes in the quarterly list.

2. Examples of notable payment shifts

   Discussion of selected drugs with larger quarter-to-quarter payment changes and how these stand out within the ASP update. The section also references usage frequency and CMS timing for published prices.

3. Changes could come mid-year

   A summary of a CMS policy update that may affect later-year ASP reporting and payment calculations. It addresses the broader pricing framework for manufacturer-reported data and related fee treatment.

4. Key ASP changes for Part B drugs for first quarter 2007

   A table-based summary of drugs with significant payment increases and decreases in the first-quarter 2007 ASP update. The section is organized by change direction and ranks drugs by claim volume.